A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Type 2 Diabetes MellitusHigh Blood Sugar

Interventions

DRUG

AZD1656

3 different formulations, A, B and C of AZD1656 assessed before food intake and formulation B also after food intake

Trial Locations (1)

Research Site, Saint Paul